Similar effects were observed for other cytotoxic drugs in NSCLC cells displaying a synergistic interaction with gefitinib, as well as with the TS-inhibitor 5-fluorouracil (5-FU) in colorectal cancer cells (Van Schaeybroeck et al, 2005, 2006). Here, TYMS is linked to non-small cell lung carcinoma.